References
Adler AC, Cestero C (2012) Symptomatic pericardial effusion in Hodgkin's lymphoma: a rare occurrence. Case report and review of the literature. Tumori 98:50e–e52
Adler Y, Charron P, Imazio M et al (2015) 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36:2921–2961
Economopoulos T, Asprou N, Stathakis N, Papageorgiou E, Dervenoulas J, Xanthaki K, Raptis S (1996) Primary extranodal non-Hodgkin’s lymphoma in adults: clinicopathological and survival characteristics. Leuk Lymphoma 21:131–136
Ferry JA (2008) Extranodal lymphoma. Arch Pathol Lab Med 132:565–578
Gordon MJ, Danilova O, Spurgeon S, Danilov AV (2016) Cardiac non-Hodgkin’s lymphoma: clinical characteristics and trends in survival. Eur J Haematol 97:445–452
Howlett C, Snedecor SJ, Landsburg DJ et al (2015) Front-line, dose-escalatedimmunochemotherapy is associated with a significant progression-freesurvival advantage in patients with double-hit lymphomas: a system-atic review and meta-analysis. Br J Haematol 170(4):504–514
Huang LJ, Medeiros P, Lin W, Wang GT et al (2018) MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas. Mod Pathol 31:1470–1478
Landsburg DJ, Falkiewicz MK, Maly J et al (2017) Outcomes of patients withdouble-hit lymphoma who achieve first complete remission. J ClinOncol 35(20):2260–2267. https://doi.org/10.1200/JCO.2017.72.215722.DAVIES
Mendeville M, Roemer MGM, van den Hout MFCM et al (2019) Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma. Blood 133(4):377–380. https://doi.org/10.1182/blood-2017-12-822171
Neragi-Miandoab S, Kim J, Vlahakes GJ (2007) Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol) 19:748–756
Petrich A, Cho SI, Billett H (2011) Primary cardiac lymphoma. Cancer 117:581–589
Petrich AM, Gandhi M, Jovanovic B et al (2014) Impact of induction regimenand stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood 124(15):2354–2361
Sanna P, Bertoni F, Zucca E, Roggero E, Passega Sidler E, Fiori G, Pedrinis E, Mombelli G, Cavalli F (1998) Cardiac involvement in HIV-related non-Hodgkin’s lymphoma: a case report and short review of the literature. Ann Hematol 77(1–2):75–78
Simonelli C, Spina M, Cinelli R et al (2003) Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol 21(21):3948–3954
Vaitkus PT, Herrmann HC, LeWinter MM (1994) Treatment of malignant pericardial effusion. JAMA 272:59–64
Funding
The authors received no specific funding for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
Ethics committee is not required for the publication of this single case report. Details that might disclose the identity of the patient are not included in this manuscript.
Informed consent
Authors obtained oral informed patient’s consent to publication before submitting the article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Efstathopoulou, A., Ghielmini, M. & Zucca, E... MYC/BCL2/BCL6 triple hit lymphoma of the pericardium: a case report and review of the literature. J Cancer Res Clin Oncol 146, 2435–2438 (2020). https://doi.org/10.1007/s00432-020-03137-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-020-03137-6